Devyser Diagnostics AB (DVYSR) — Cash Flow-to-Debt Ratio
Devyser Diagnostics AB (DVYSR) has a Cash Flow-to-Debt Ratio of 0.11x as of March 2026, meaning its operating cash flow of Skr12.10 Million could theoretically repay 0% of its total liabilities (Skr112.20 Million) in one year. Check Devyser Diagnostics AB (DVYSR) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Devyser Diagnostics AB Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Devyser Diagnostics AB across 8 annual periods. Also explore balance sheet size of Devyser Diagnostics AB for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Devyser Diagnostics AB (2018–2025)
Year-by-year debt coverage analysis for Devyser Diagnostics AB. For market capitalisation and broader financial context, see Devyser Diagnostics AB stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | Skr8.20 Million | Skr115.40 Million | ▲ +118.9% |
| 2024 | -0.38x | Skr-46.80 Million | Skr124.80 Million | ▲ +32.7% |
| 2023 | -0.56x | Skr-69.70 Million | Skr125.00 Million | ▲ +4.7% |
| 2022 | -0.59x | Skr-40.50 Million | Skr69.19 Million | ▼ -42.7% |
| 2021 | -0.41x | Skr-16.48 Million | Skr40.18 Million | ▼ -2951.1% |
| 2020 | 0.01x | Skr627.00K | Skr43.58 Million | ▼ -96.4% |
| 2019 | 0.40x | Skr14.63 Million | Skr36.69 Million | ▲ +20.9% |
| 2018 | 0.33x | Skr6.02 Million | Skr18.25 Million | — |